(Q37776514)

23 August 2017

1 reference

title

Cell therapy for heart failure: the need for a new therapeutic strategy (English)

1 reference

23 August 2017

0 references

Christopher M O'Connor

series ordinal

2

object named as

Christopher M O'Connor

1 reference

23 August 2017

Thomas J Povsic

1

1 reference

23 August 2017

1 August 2010

1 reference

Expert Review of Cardiovascular Therapy

23 August 2017

1 reference

23 August 2017

8

1 reference

23 August 2017

8

1 reference

23 August 2017

1107-1126

1 reference

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

23 August 2017

1 reference

The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications

21 January 2018

1 reference

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

21 January 2018

1 reference

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

21 January 2018

1 reference

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial

21 January 2018

1 reference

Left ventricular assist device and drug therapy for the reversal of heart failure

21 January 2018

1 reference

Cardiac resynchronization in chronic heart failure

21 January 2018

1 reference

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

21 January 2018

1 reference

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

21 January 2018

1 reference

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

Stem cells as a source of regenerative cardiomyocytes

21 January 2018

1 reference

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection.

21 January 2018

1 reference

Monitoring of bone marrow cell homing into the infarcted human myocardium

21 January 2018

1 reference

Images in cardiovascular medicine. Early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in a patient with acute myocardial infarction.

21 January 2018

1 reference

Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium.

21 January 2018

1 reference

Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure.

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.

21 January 2018

1 reference

Bioengineered cardiac cell sheet grafts have intrinsic angiogenic potential.

21 January 2018

1 reference

Fibroblast sheets co-cultured with endothelial progenitor cells improve cardiac function of infarcted hearts

21 January 2018

1 reference

Cell sheet engineering for heart tissue repair

21 January 2018

1 reference

Cardiac tissue engineering using stem cells

21 January 2018

1 reference

Transcoronary transplantation of progenitor cells after myocardial infarction

21 January 2018

1 reference

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

21 January 2018

1 reference

Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging

21 January 2018

1 reference

Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT.

21 January 2018

1 reference

Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI).

21 January 2018

1 reference

Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.

21 January 2018

1 reference

Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl

21 January 2018

1 reference

Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction

21 January 2018

1 reference

Atorvastatin reduces tissue factor expression in adipose tissue of atherosclerotic rabbits.

21 January 2018

1 reference

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

21 January 2018

1 reference

Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function.

21 January 2018

1 reference

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

21 January 2018

1 reference

Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial

21 January 2018

1 reference

Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study.

21 January 2018

1 reference

Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans

21 January 2018

1 reference

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

21 January 2018

1 reference

The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction

21 January 2018

1 reference

Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment

21 January 2018

1 reference

Do medical devices have enhanced placebo effects?

21 January 2018

1 reference

Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial.

21 January 2018

1 reference

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

21 January 2018

1 reference

Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis

21 January 2018

1 reference

Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis

21 January 2018

1 reference

Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.

21 January 2018

1 reference

Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases

21 January 2018

1 reference

Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction

21 January 2018

1 reference

Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meeting

21 January 2018

1 reference

Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure

21 January 2018

1 reference

Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry.

21 January 2018

1 reference

Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease

21 January 2018

1 reference

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

21 January 2018

1 reference

Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.

21 January 2018

1 reference

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction

21 January 2018

1 reference

Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy

21 January 2018

1 reference

Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study

21 January 2018

1 reference

Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results

21 January 2018

1 reference

Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.

21 January 2018

1 reference

Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation

21 January 2018

1 reference

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial

21 January 2018

1 reference

Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy

21 January 2018

1 reference

Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischemic heart disease

21 January 2018

1 reference

Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study

21 January 2018

1 reference

Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure

21 January 2018

1 reference

21 January 2018

Human cardiac stem cells

1 reference

Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure

21 January 2018

1 reference

Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.

21 January 2018

1 reference

Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction

21 January 2018

1 reference

Cell-based myocardial repair: how should we proceed?

21 January 2018

1 reference

Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up

21 January 2018

1 reference

Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up.

21 January 2018

1 reference

Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients.

21 January 2018

1 reference

Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction

21 January 2018

1 reference

Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial.

21 January 2018

1 reference

Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up.

21 January 2018

1 reference

Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up

21 January 2018

1 reference

Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study

21 January 2018

1 reference

One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study).

21 January 2018

1 reference

Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation

21 January 2018

1 reference

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

21 January 2018

1 reference

Bone marrow cells regenerate infarcted myocardium

21 January 2018

1 reference

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium

21 January 2018

1 reference

Cell-based therapy of myocardial infarction

21 January 2018

1 reference

Paracrine mechanisms in adult stem cell signaling and therapy

21 January 2018

1 reference

Clinical applications of stem cells for the heart

21 January 2018

1 reference

21 January 2018

Cardiac regeneration.

1 reference

Adult cardiac stem cells are multipotent and support myocardial regeneration

21 January 2018

1 reference

Evidence that human cardiac myocytes divide after myocardial infarction

21 January 2018

1 reference

Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion.

21 January 2018

1 reference

Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens.

21 January 2018

1 reference

Evolution of the c-kit-positive cell response to pathological challenge in the myocardium

21 January 2018

1 reference

Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages

21 January 2018

1 reference

Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes

21 January 2018

1 reference

The post-natal heart contains a myocardial stem cell population.

21 January 2018

1 reference

Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart

21 January 2018

1 reference

Stem cells in the heart: what's the buzz all about?--Part 1: preclinical considerations

21 January 2018

1 reference

Stem cells in the heart: what's the buzz all about? Part 2: Arrhythmic risks and clinical studies.

21 January 2018

1 reference

Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction

21 January 2018

1 reference

Imaging survival and function of transplanted cardiac resident stem cells

21 January 2018

1 reference

Cardiomyocytes can be generated from marrow stromal cells in vitro

21 January 2018

1 reference

Advances in cell-based therapy for structural heart disease

21 January 2018

1 reference

Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche.

21 January 2018

1 reference

Early improvement in cardiac tissue perfusion due to mesenchymal stem cells.

21 January 2018

1 reference

Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep

21 January 2018

1 reference

Differentiation of pluripotent embryonic stem cells into cardiomyocytes.

21 January 2018

1 reference

Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats.

21 January 2018

1 reference

Guided stem cell cardiopoiesis: discovery and translation

21 January 2018

1 reference

Cardiopoietic programming of embryonic stem cells for tumor-free heart repair

21 January 2018

1 reference

Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report.

21 January 2018

1 reference

A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow

21 January 2018

1 reference

Morphological characterization of very small embryonic-like stem cells (VSELs) by ImageStream system analysis

21 January 2018

1 reference

Bone marrow-derived pluripotent very small embryonic-like stem cells (VSELs) are mobilized after acute myocardial infarction

21 January 2018

1 reference

Transplantation of bone marrow-derived very small embryonic-like stem cells attenuates left ventricular dysfunction and remodeling after myocardial infarction

21 January 2018

1 reference

Pilot study of rapid infusion of 2 L of 4 degrees C normal saline for induction of mild hypothermia in hospitalized, comatose survivors of out-of-hospital cardiac arrest

21 January 2018

1 reference

Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model.

21 January 2018

1 reference

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

Reprogramming of human somatic cells to pluripotency with defined factors

21 January 2018

1 reference

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

Generation of functional murine cardiac myocytes from induced pluripotent stem cells

21 January 2018

1 reference

Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells

21 January 2018

1 reference

Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.

21 January 2018

1 reference

Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages

21 January 2018

1 reference

Functional cardiomyocytes derived from human induced pluripotent stem cells

21 January 2018

1 reference

iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism

21 January 2018

1 reference

A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates.

21 January 2018

1 reference

Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions

21 January 2018

1 reference

Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease.

21 January 2018

1 reference

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

21 January 2018

1 reference

Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat

21 January 2018

1 reference

Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction

21 January 2018

1 reference

Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium

21 January 2018

1 reference

Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function

21 January 2018

1 reference

Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERC.10.99

1 reference

23 August 2017

1 reference

PubMed ID

20670189